Marimed Inc
MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States and internationally. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand; and cannabis-infused ice creams under Emack & Bolio's bra… Read more
Market Cap & Net Worth: Marimed Inc (MRMD)
Marimed Inc (OTCQX:MRMD) has a market capitalization of $39.11 Million ($39.11 Million) as of March 18, 2026. Listed on the OTCQX stock exchange, this USA-based company holds position #23289 globally and #8159 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Marimed Inc's stock price $0.10 by its total outstanding shares 395073625 (395.07 Million).
Marimed Inc Market Cap History: 2015 to 2025
Marimed Inc's market capitalization history from 2015 to 2025. Data shows growth from $59.26 Million to $39.11 Million (4.52% CAGR).
Marimed Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Marimed Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.37x
Marimed Inc's market cap is 0.37 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $59.26 Million | $1.27 Million | -$1.22 Million | 46.66x | N/A |
| 2016 | $92.84 Million | $3.56 Million | -$198.85K | 26.05x | N/A |
| 2017 | $272.60 Million | $6.07 Million | -$1.19 Million | 44.93x | N/A |
| 2018 | $1.28 Billion | $11.85 Million | -$13.60 Million | 108.34x | N/A |
| 2019 | $244.08 Million | $45.60 Million | -$81.18 Million | 5.35x | N/A |
| 2020 | $185.68 Million | $50.90 Million | $2.14 Million | 3.65x | 86.61x |
| 2021 | $341.74 Million | $121.46 Million | $7.22 Million | 2.81x | 47.30x |
| 2022 | $140.65 Million | $134.01 Million | $13.47 Million | 1.05x | 10.44x |
| 2023 | $108.65 Million | $148.60 Million | -$16.03 Million | 0.73x | N/A |
| 2024 | $58.08 Million | $157.96 Million | -$12.16 Million | 0.37x | N/A |
Competitor Companies of MRMD by Market Capitalization
Companies near Marimed Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Marimed Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Marimed Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Marimed Inc's market cap moved from $59.26 Million to $ 39.11 Million, with a yearly change of 4.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $39.11 Million | -32.65% |
| 2024 | $58.08 Million | -46.55% |
| 2023 | $108.65 Million | -22.75% |
| 2022 | $140.65 Million | -58.84% |
| 2021 | $341.74 Million | +84.04% |
| 2020 | $185.68 Million | -23.92% |
| 2019 | $244.08 Million | -80.99% |
| 2018 | $1.28 Billion | +371.01% |
| 2017 | $272.60 Million | +193.62% |
| 2016 | $92.84 Million | +56.67% |
| 2015 | $59.26 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Marimed Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.11 Million USD |
| MoneyControl | $39.11 Million USD |
| MarketWatch | $39.11 Million USD |
| marketcap.company | $39.11 Million USD |
| Reuters | $39.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.